Skip to main content
. 2020 May 22;42(2):96–106. doi: 10.4082/kjfm.20.0025

Table 2.

Pain intensity differences of all groups*

Variable Group 1 (n=24)
Group 2 (n=24)
Group 3 (n=22)
Group 4 (n=20)
Comparison of groups (P-value)
Mean 25% 75% Mean 25% 75% Mean 25% 75% Mean 25% 75% 1–2 1–3 1–4 2–3 2–4 3–4
Pain at activity (BT) 5.5 4 7 6 4 7 5 4 7.25 5 3.25 6.75 0.410 0.600 0.793 0.929 0.398 0.451
Pain at activity (4 wk) 1.5 0 3 0 0 3.75 2.5 0.75 4.25 0 0 3 0.536 0.153 0.363 0.064 0.801 0.037
Pain at activity (8 wk) 0 0 1 0 0 0 0 0 2 0 0 0 0.227 0.533 0.149 0.081 0.698 0.056
P-value
BT–4 wk <0.001 <0.001 <0.001 <0.001
AT–8 wk <0.001 <0.001 <0.001 <0.001
4–8 wk 0.001 0.007 0.001 0.011
Pain at night (BT) 0.5 0 4.75 4 0 5.75 3.5 0 5 1 0 5 0.196 0.504 0.920 0.521 0.294 0.654
Pain at night (4 wk) 0 0 0 0 0 0 0 0 1.5 0 0 0 1.000 0.146 0.700 0.146 0.700 0.359
Pain at night (8 wk) 0 0 0 0 0 0 0 0 0 0 0 0 0.317 0.280 0.400 0.064 1.000 0.118
P-value
BT–4 wk 0.001 <0.001 0.001 0.005
AT–8 wk 0.002 <0.001 0.001 0.01
4–8 wk 0.002 0.068 0.015 0.066
Pain at rest (BT) 1.5 0 6 4 1 6 3 2 5 4 2 5 0.271 0.409 0.267 0.430 0.651 0.683
Pain at rest (4 wk) 0 0 0.75 0 0 0 1 0 2 0 0 0 0.039 0.130 0.324 <0.001 0.228 0.008
Pain at rest (8 wk) 0 0 0 0 0 0 0 0 0 0 0 0 0.153 0.555 0.228 0.064 1.000 0.118
P-value
BT–4 wk 0.001 <0.001 <0.001 <0.001
AT–8 wk 0.001 <0.001 <0.001 0.001
4–8 wk 0.042 0.317 0.003 0.18

P<0.05 values are presented in bold.

BT, before treatment; AT, after treatment.

*

By two-way analysis of variance test.

HHS Vulnerability Disclosure